2. Beecher HK, Todd DP. A study of the deaths associated with anesthesia and surgery: based on a study of 599, 548 anesthesias in ten institutions 1948-1952, inclusive. Ann Surg 1954; 140: 2-35. PMID:
10.1097/00000658-195407000-00001. PMID:
13159140. PMID:
PMC1609600.
3. Christie TH, Churchill-Davidson HC. The St. Thomas’s Hospital nerve stimulator in the diagnosis of prolonged apnoea. Lancet 1958; 1: 776PMID:
10.1016/S0140-6736(58)91583-6.
4. Ali HH, Utting JE, Gray TC. Quantitative assessment of residual antidepolarizing block. I. Br J Anaesth 1971; 43: 473-7. PMID:
10.1093/bja/43.5.473. PMID:
4254031.
5. Baillard C, Clec’h C, Catineau J, Salhi F, Gehan G, Cupa M, et al. Postoperative residual neuromuscular block: a survey of management. Br J Anaesth 2005; 95: 622-6. PMID:
10.1093/bja/aei240. PMID:
16183681.
7. Eriksson LI, Lennmarken C, Wyon N, Johnson A. Attenuated ventilatory response to hypoxaemia at vecuronium-induced partial neuromuscular block. Acta Anaesthesiol Scand 1992; 36: 710-5. PMID:
10.1111/j.1399-6576.1992.tb03550.x. PMID:
1359723.
8. Eriksson LI, Sundman E, Olsson R, Nilsson L, Witt H, Ekberg O, et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology 1997; 87: 1035-43. PMID:
10.1097/00000542-199711000-00005. PMID:
9366453.
9. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skovgaard LT, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997; 41: 1095-103. PMID:
10.1111/j.1399-6576.1997.tb04851.x. PMID:
9366929.
10. Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 2003; 98: 1042-8. PMID:
10.1097/00000542-200305000-00004. PMID:
12717123.
11. Baillard C, Gehan G, Reboul-Marty J, Larmignat P, Samama CM, Cupa M. Residual curarization in the recovery room after vecuronium. Br J Anaesth 2000; 84: 394-5. PMID:
10.1093/oxfordjournals.bja.a013445. PMID:
10793602.
12. Lee JS, Han SY, Cho SH, Chung JW, Kim SH, Chai WS, et al. Postoperative residual curarization in the recovery room after vecuronium or rocuronium use. Anesth Pain Med 2006; 1: 101-5.
13. Lee JS, Gong HY, Cho SH, Kim SH, Chai WS, Jin HC. Validity and reliability of head lift and tongue depressor test for diagnosis of the residual block. Anesth Pain Med 2009; 4: 146-50.
14. Mortensen CR, Berg H, el-Mahdy A, Viby-Mogensen J. Perioperative monitoring of neuromuscular transmission using acceleromyography prevents residual neuromuscular block following pancuronium. Acta Anaesthesiol Scand 1995; 39: 797-801. PMID:
10.1111/j.1399-6576.1995.tb04173.x. PMID:
7484037.
15. Scott MJ, Baldini G, Fearon KC, Feldheiser A, Feldman LS, Gan TJ, et al. Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 1: pathophysiological considerations. Acta Anaesthesiol Scand 2015; 59: 1212-31. PMID:
10.1111/aas.12601. PMID:
26346577. PMID:
PMC5049676.
16. Seo HJ, Lee YK, Lee SS, Kim KS, Yang HS. A survey of postoperative residual neuromuscular block and neuromuscular monitoring. Anesth Pain Med 2010; 5: 70-4.
17. Fruergaard K, Viby-Mogensen J, Berg H, el-Mahdy AM. Tactile evaluation of the response to double burst stimulation decreases, but does not eliminate, the problem of postoperative residual paralysis. Acta Anaesthesiol Scand 1998; 42: 1168-74. PMID:
10.1111/j.1399-6576.1998.tb05271.x. PMID:
9834799.
18. Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010; 111: 120-8. PMID:
10.1213/ane.0b013e3181da832d.
19. Viby-Mogensen J, Jensen NH, Engbaek J, Ording H, Skovgaard LT, Chraemmer-Jørgensen B. Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology 1985; 63: 440-3. PMID:
10.1097/00000542-198510000-00015. PMID:
4037404.
20. Engbaek J, Ostergaard D, Viby-Mogensen J. Double burst stimulation (DBS): a new pattern of nerve stimulation to identify residual neuromuscular block. Br J Anaesth 1989; 62: 274-8. PMID:
10.1093/bja/62.3.274. PMID:
2522790.
21. Drenck NE, Ueda N, Olsen NV, Engbaek J, Jensen E, Skovgaard LT, et al. Manual evaluation of residual curarization using double burst stimulation: a comparison with train-of-four. Anesthesiology 1989; 70: 578-81. PMID:
10.1097/00000542-198904000-00003. PMID:
2929994.
22. Eriksson LI. Evidence-based practice and neuromuscular monitoring: it’s time for routine quantitative assessment. Anesthesiology 2003; 98: 1037-9. PMID:
10.1097/00000542-200305000-00002. PMID:
12717121.
23. Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 2007; 51: 789-808. PMID:
10.1111/j.1399-6576.2007.01352.x. PMID:
17635389.
24. Brull SJ, Silverman DG. Pulse width, stimulus intensity, electrode placement, and polarity during assessment of neuromuscular block. Anesthesiology 1995; 83: 702-9. PMID:
10.1097/00000542-199510000-00009.
25. Brull SJ, Silverman DG. Real time versus slow-motion train-of-four monitoring: a theory to explain the inaccuracy of visual assessment. Anesth Analg 1995; 80: 548-51. PMID:
10.1097/00000539-199503000-00020.
26. Pansard JL, Chauvin M, Lebrault C, Gauneau P, Duvaldestin P. Effect of an intubating dose of succinylcholine and atracurium on the diaphragm and the adductor pollicis muscle in humans. Anesthesiology 1987; 67: 326-30. PMID:
10.1097/00000542-198709000-00008. PMID:
3631606.
27. Donati F, Antzaka C, Bevan DR. Potency of pancuronium at the diaphragm and the adductor pollicis muscle in humans. Anesthesiology 1986; 65: 1-5. PMID:
10.1097/00000542-198607000-00001. PMID:
3729027.
28. Michaud G, Trager G, Deschamps S, Hemmerling TM. Dominance of the hand does not change the phonomyographic measurement of neuromuscular block at the adductor pollicis muscle. Anesth Analg 2005; 100: 718-21. PMID:
10.1213/01.ANE.0000144067.42615.AD. PMID:
15728058.
29. Claudius C, Skovgaard LT, Viby-Mogensen J. Arm-to-arm variation when evaluating neuromuscular block: an analysis of the precision and the bias and agreement between arms when using mechanomyography or acceleromyography. Br J Anaesth 2010; 105: 310-7. PMID:
10.1093/bja/aeq162. PMID:
20595196.
30. Lee S, Yang HS, Sasakawa T, Khan MA, Khatri A, Kaneki M, et al. Immobilization with atrophy induces de novo expression of neuronal nicotinic α7 acetylcholine receptors in muscle contributing to neurotransmission. Anesthesiology 2014; 120: 76-85. PMID:
10.1097/ALN.0000000000000025. PMID:
24126263. PMID:
PMC3910258.
31. Kim KS, Jeon JW, Koh MS, Shim JH, Cho SY, Suh JK. The duration of immobilization causes the changing pharmacodynamics of mivacurium and rocuronium in rabbits. Anesth Analg 2003; 96: 438-42. PMID:
10.1097/00000539-200302000-00027. PMID:
12538193.
32. Godai K, Hasegawa-Moriyama M, Kuniyoshi T, Kakoi T, Ikoma K, Isowaki S, et al. Three cases of suspected sugammadex-induced hypersensitivity reactions. Br J Anaesth 2012; 109: 216-8. PMID:
10.1093/bja/aes137. PMID:
22617091.
33. Tsur A, Kalansky A. Hypersensitivity associated with sugammadex administration: a systematic review. Anaesthesia 2014; 69: 1251-7. PMID:
10.1111/anae.12736. PMID:
24848211.
34. Le Corre F, Nejmeddine S, Fatahine C, Tayar C, Marty J, Plaud B. Recurarization after sugammadex reversal in an obese patient. Can J Anaesth 2011; 58: 944-7. PMID:
10.1007/s12630-011-9554-y. PMID:
21751072.
35. Kotake Y, Ochiai R, Suzuki T, Ogawa S, Takagi S, Ozaki M, et al. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg 2013; 117: 345-51. PMID:
10.1213/ANE.0b013e3182999672. PMID:
23757472.
36. Ledowski T, Ong JS, Flett T. Neuromuscular monitoring, muscle relaxant use, and reversal at a tertiary teaching hospital 2.5 years after introduction of sugammadex: changes in opinions and clinical practice. Anesthesiol Res Pract 2015; 2015: 367-937.
37. Van Lancker P, Dillemans B, Bogaert T, Mulier JP, De Kock M, Haspeslagh M. Ideal versus corrected body weight for dosage of sugammadex in morbidly obese patients. Anaesthesia 2011; 66: 721-5. PMID:
10.1111/j.1365-2044.2011.06782.x. PMID:
21692760.
38. Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg 2010; 111: 110-9. PMID:
19910616.
41. Feldheiser A, Aziz O, Baldini G, Cox BP, Fearon KC, Feldman LS, et al. Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice. Acta Anaesthesiol Scand 2016; 60: 289-334. PMID:
10.1111/aas.12651. PMID:
26514824. PMID:
PMC5061107.
42. Merry AF, Cooper JB, Soyannwo O, Wilson IH, Eichhorn JH. International standards for a safe practice of anesthesia. Can J Anaesth 2010; 57: 1027-34. PMID:
10.1007/s12630-010-9381-6. PMID:
20857254. PMID:
PMC2957572.
43. Checketts MR, Alladi R, Ferguson K, Gemmell L, Handy JM, Klein AA, et al. Recommendations for standards of monitoring during anaesthesia and recovery. 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia 2016; 71: 85-93. PMID:
10.1111/anae.13421. PMID:
26582586. PMID:
PMC5063182.